Lorlatinib Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of lorlatinib that may be used in the treatment of ALK-positive or ROS1-positive advanced non-small cell lung cancer (NSCLC), uterine sarcoma, diffuse large B-cell lymphoma (DLBCL), T-cell lymphomas, inflammatory myofibroblastic tumor (IMT), and certain histiocytic neoplasms, such as Erdheim-Chester disease.

**Synonyms:** - Lorbrena Regimen - Lorlatinib monotherapy